{"id":"https://openalex.org/W62565176","doi":null,"title":"The effect of a combined administration of ridogrel and ketanserin in patients with intermittent claudication.","display_name":"The effect of a combined administration of ridogrel and ketanserin in patients with intermittent claudication.","publication_year":1993,"publication_date":"1993-03-01","ids":{"openalex":"https://openalex.org/W62565176","mag":"62565176","pmid":"https://pubmed.ncbi.nlm.nih.gov/8376914"},"language":"en","primary_location":{"id":"pmid:8376914","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8376914","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International angiology : a journal of the International Union of Angiology","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071596419","display_name":"J. De Cr\u00e9e","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J De Cree","raw_affiliation_strings":["Clinical Research Unit St. Bartholomeus, Jan Palfijn Hospital, Merksem, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Unit St. Bartholomeus, Jan Palfijn Hospital, Merksem, Belgium","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022967538","display_name":"Hedwig Geukens","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H Geukens","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027082138","display_name":"Ph. Gutwirth","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P Gutwirth","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108502259","display_name":"Fred De Clerck","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F De Clerck","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068874945","display_name":"Els Vercammen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E Vercammen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5091875642","display_name":"Herman Verhaegen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H Verhaegen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.00845044,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"12","issue":"1","first_page":"59","last_page":"68"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10926","display_name":"Peripheral Artery Disease Management","score":0.8647000193595886,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10926","display_name":"Peripheral Artery Disease Management","score":0.8647000193595886,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.11800000071525574,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.007499999832361937,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ridogrel","display_name":"ridogrel","score":0.9829999804496765},{"id":"https://openalex.org/keywords/ketanserin","display_name":"ketanserin","score":1.0},{"id":"https://openalex.org/keywords/intermittent-claudication","display_name":"intermittent claudication","score":0.996999979019165},{"id":"https://openalex.org/keywords/peripheral-arterial-disease","display_name":"peripheral arterial disease","score":0.8709999918937683},{"id":"https://openalex.org/keywords/thromboxane-synthase-inhibitor","display_name":"thromboxane synthetase inhibitor","score":0.7670000195503235},{"id":"https://openalex.org/keywords/thromboxane-receptor-antagonist","display_name":"thromboxane A2 receptor antagonist","score":0.9110000133514404},{"id":"https://openalex.org/keywords/5-ht2-receptor-antagonist","display_name":"5-HT2 receptor antagonist","score":0.9190000295639038},{"id":"https://openalex.org/keywords/platelet-inhibition","display_name":"platelet aggregation inhibition","score":0.8930000066757202},{"id":"https://openalex.org/keywords/prostanoids","display_name":"prostanoids","score":0.7450000047683716},{"id":"https://openalex.org/keywords/thromboxane-b2","display_name":"thromboxane B2","score":0.8880000114440918},{"id":"https://openalex.org/keywords/walking-distance","display_name":"walking distance","score":0.6880000233650208},{"id":"https://openalex.org/keywords/claudication-pain","display_name":"claudication pain","score":0.7730000019073486},{"id":"https://openalex.org/keywords/bleeding-time","display_name":"bleeding time","score":0.7329999804496765}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8639758825302124},{"id":"https://openalex.org/C2776785769","wikidata":"https://www.wikidata.org/wiki/Q412212","display_name":"Thromboxane","level":3,"score":0.6728907227516174},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6569792032241821},{"id":"https://openalex.org/C2777785214","wikidata":"https://www.wikidata.org/wiki/Q415997","display_name":"Ketanserin","level":5,"score":0.6251465082168579},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.4853178858757019},{"id":"https://openalex.org/C2779881954","wikidata":"https://www.wikidata.org/wiki/Q1097957","display_name":"Intermittent claudication","level":4,"score":0.48473307490348816},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.4284045696258545},{"id":"https://openalex.org/C2781080829","wikidata":"https://www.wikidata.org/wiki/Q3009646","display_name":"Thromboxane B2","level":3,"score":0.42827916145324707},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.42391467094421387},{"id":"https://openalex.org/C2780664492","wikidata":"https://www.wikidata.org/wiki/Q209717","display_name":"Prostaglandin","level":2,"score":0.41348177194595337},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.36734718084335327},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3632228374481201},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.17146769165992737},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.166334867477417},{"id":"https://openalex.org/C2777466421","wikidata":"https://www.wikidata.org/wiki/Q1266890","display_name":"Vascular disease","level":2,"score":0.144124835729599},{"id":"https://openalex.org/C53910766","wikidata":"https://www.wikidata.org/wiki/Q238516","display_name":"5-HT receptor","level":4,"score":0.0940021276473999},{"id":"https://openalex.org/C3018348675","wikidata":"https://www.wikidata.org/wiki/Q4797557","display_name":"Arterial disease","level":3,"score":0.06310990452766418},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007383","descriptor_name":"Intermittent Claudication","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D007383","descriptor_name":"Intermittent Claudication","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007383","descriptor_name":"Intermittent Claudication","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D007650","descriptor_name":"Ketanserin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007650","descriptor_name":"Ketanserin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010421","descriptor_name":"Pentanoic Acids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010421","descriptor_name":"Pentanoic Acids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013930","descriptor_name":"Thromboxane-A Synthase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:8376914","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8376914","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International angiology : a journal of the International Union of Angiology","raw_type":"Clinical Trial"},{"id":"mag:62565176","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8376914","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4206586840","https://openalex.org/W2093016612","https://openalex.org/W2150419292","https://openalex.org/W2472521610","https://openalex.org/W2465732382","https://openalex.org/W2051793253","https://openalex.org/W2460490661","https://openalex.org/W2015959564","https://openalex.org/W4291311646","https://openalex.org/W2093854873"],"abstract_inverted_index":{"After":[0],"a":[1,16,44,62,113,169,201,248,263],"1-month":[2],"placebo":[3,19],"run-in":[4],"phase,":[5],"27":[6],"patients":[7],"with":[8,143,152,177],"proven":[9],"peripheral":[10],"arterial":[11],"obstructive":[12],"disease":[13],"participated":[14],"in":[15,25,164,181,274],"double":[17],"blind":[18],"controlled":[20],"study":[21],"and":[22,39,51,89,97,109,134,179,189,215,244,267],"were":[23,117,127,140,150,191],"divided":[24],"3":[26],"groups,":[27,71],"receiving":[28],"either":[29],"placebo,":[30],"ridogrel":[31,47,178,266],"300":[32,48],"mg":[33,49,54],"b.i.d.":[34,50],"(a":[35,56],"combined":[36,175],"thromboxane":[37,75,114],"synthase":[38],"receptor":[40,59],"blocking":[41],"agent)":[42],"or":[43],"combination":[45,264],"of":[46,64,74,81,85,99,156,196,218,237,251,265,271,277],"ketanserin":[52,180,268],"20":[53],"t.i.d.":[55],"5-HT2":[57],"serotonergic":[58],"antagonist)":[60],"for":[61],"period":[63,173],"1":[65],"month.":[66],"In":[67,168],"both":[68,121],"active":[69,145],"treatment":[70,122,176,276],"serum":[72],"levels":[73,84,98,133],"B2":[76],"decreased":[77],"significantly":[78,118,128,204,222,245],"to":[79,95,210,228,255],"3%":[80],"baseline.":[82],"The":[83,193],"6-keto-prostaglandin":[86],"F1":[87],"alpha":[88,92],"prostaglandin":[90,100],"F2":[91],"increased":[93],"two-":[94],"three-fold":[96],"E2":[101],"6":[102],"times.":[103],"Platelet":[104],"aggregation":[105,160],"induced":[106],"by":[107,110,120],"collagen":[108],"U":[111],"46619,":[112],"A2":[115],"mimetic,":[116],"inhibited":[119],"regimen.":[123],"Template":[124],"bleeding":[125],"times":[126],"prolonged":[129],"but":[130],"plasma":[131],"fibrinogen":[132],"the":[135,144,157,165,184,197,216,234,238,275],"activated":[136],"partial":[137],"thromboplastin":[138],"time":[139],"not":[141],"affected":[142],"treatments.":[146],"No":[147],"such":[148],"changes":[149],"seen":[151,163],"placebo.":[153],"An":[154],"inhibition":[155],"serotonin-induced":[158],"platelet":[159,187],"was":[161],"only":[162],"ketanserin-treated":[166],"group.":[167],"3-month":[170],"open":[171],"follow-up":[172],"during":[174],"22":[182],"patients,":[183],"effects":[185],"on":[186,200],"function":[188],"prostanoids":[190],"maintained.":[192],"total":[194],"duration":[195],"walking":[198],"distance":[199],"treadmill":[202],"improved":[203,221,246],"from":[205,223,247],"323":[206],"+/-":[207,212,225,230,253,257],"53":[208],"seconds":[209,214,227],"399":[211],"48":[213],"onset":[217],"claudication":[219],"pain":[220],"121":[224],"29":[226],"212":[229],"44":[231],"seconds,":[232],"whereas":[233],"maximal":[235],"drop":[236],"post-exercise":[239],"ankle/arm":[240],"pressure":[241],"gradient":[242],"markedly":[243],"control":[249],"value":[250,273],"0.38":[252],"0.05":[254],"0.51":[256],"0.05.":[258],"These":[259],"findings":[260],"suggest":[261],"that":[262],"may":[269],"be":[270],"therapeutic":[272],"intermittent":[278],"claudication.":[279]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}